Jane Street
RKDA icon

Jane Street’s Arcadia Biosciences RKDA Stock Holding History

Jane Street’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,364
Closed -$14.8K – 9777
2022
Q4 		$14.8K Buy
1,364
+818
+150% +$11.7K ﹤0.01% 8675
2022
Q3 		$12K Buy
+546
New +$18.6K ﹤0.01% 9315
2022
Q2 		– Sell
-912
Closed -$51K – 10681
2022
Q1 		$51K Buy
912
+623
+216% +$29.7K ﹤0.01% 9687
2021
Q4 		$12K Buy
+289
New +$18.8K ﹤0.01% 9883
2021
Q3 		– Sell
-489
Closed -$58K – 10593
2021
Q2 		$58K Buy
+489
New +$53.3K ﹤0.01% 9471
2019
Q4 		– Sell
-284
Closed -$53K – 5634
2019
Q3 		$53K Buy
+284
New +$54.5K ﹤0.01% 4877

Other funds holding RKDA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jane Street's RKDA Position: Q1 2023 in Review

Jane Street sold out of Arcadia Biosciences (RKDA) in Q1 2023, closing a stake of 1,364 shares — an estimated $14.8K sold.

Jane Street first reported a position in RKDA in Q3 2019 and held it in 6 quarters. The position peaked at $58K in Q2 2021. 15 funds tracked by Wall St. Rank hold RKDA as of Q1 2023.

  • Jane Street reported no remaining Arcadia Biosciences position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 1,364 Arcadia Biosciences shares in Q1 2023, an estimated $14.8K.
  • Jane Street first reported a position in Arcadia Biosciences in Q3 2019 and held it in 6 quarters.
  • Jane Street's Arcadia Biosciences position peaked at $58K in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.